Understanding Treatment Patterns and Costs of Myasthenia Gravis in the Czech Republic
Author Information
Author(s): Donin Gleb, Mothejlová Karla, Horáková Magda, Vohanka Stanislav
Primary Institution: Czech Technical University in Prague
Hypothesis
What are the treatment patterns and direct medical costs associated with myasthenia gravis in the Czech Republic?
Conclusion
The study provides insights into the treatment patterns and costs of myasthenia gravis, highlighting significant financial burdens from myasthenic crises and exacerbations.
Supporting Evidence
- 91.1% of patients received acetylcholine inhibitors at least once.
- 75.2% of patients were prescribed corticosteroids.
- 2% of patients experienced myasthenic crises with high hospitalization costs.
- 9.2% of patients had exacerbations with lower hospitalization costs.
- The mean total cost per patient-year was 1,271 EUR.
Takeaway
This study looks at how much it costs to treat people with a rare disease called myasthenia gravis and finds that some treatments can be very expensive.
Methodology
A descriptive cohort study using health administrative claims data from over 1,500 prevalent MG patients in the Czech Republic.
Limitations
The study is descriptive and may not capture all relevant information due to reliance on administrative claims data.
Participant Demographics
{"total":1523,"female_percentage":53,"median_age":67}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website